Market Overview

Vetr Crowd Upgrades Pfizer To Buy


The Vetr crowd on Tuesday upgraded Pfizer Inc. (NYSE: PFE) from 3 stars (Hold) to 3.5 stars (Buy). Crowd confidence was mixed, with 50 percent of the Vetr community giving the pharmaceutical giant a Buy rating, 33.3 percent a Hold rating, and 16.7 percent a Sell rating. This news comes after Pfizer presented at JP Morgan’s 36th annual Healthcare Conference.

See how crowdsourced ratings could help you time the market

Despite the company’s recent announcement that they will be ending their Alzheimer’s research, the Vetr crowd and analysts alike remained bullish. Both the Vetr crowd’s target price of $37.98 and several analyst target prices in the $37.00-$40.00 range are above the stock’s current share price of $36.44.


Related Articles (PFE)

View Comments and Join the Discussion!

Posted-In: VetrUpgrades Analyst Ratings

Latest Ratings

WKHSRoth CapitalMaintains15.0
HCKTRoth CapitalMaintains22.0
ARECRoth CapitalInitiates Coverage On7.5
SLABWells FargoMaintains180.0
PENWells FargoMaintains310.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at